- August 1, 2010 at 2:00 am
You probably already know this but if you check the archives or profiles, you might try checking with MDX, MDX-010 and MDX-101 as well as with ipilimumab. Also CTLA-4 would be another way to check. I’m sure you’ll get responses but there have been MPIP participants for as long as I’ve been here that have done some of the earlier trials and I think 4 and 5 years ago MDX was often the trial name used. I think that’s because initially Mederex was developing it with Bristol Meyer Squibb before they were bought out by BMS or that’s my recollection of the chain of events.
Best of Luck, Carver